JP4821957B2 - 高周波治療器 - Google Patents
高周波治療器 Download PDFInfo
- Publication number
- JP4821957B2 JP4821957B2 JP2005136704A JP2005136704A JP4821957B2 JP 4821957 B2 JP4821957 B2 JP 4821957B2 JP 2005136704 A JP2005136704 A JP 2005136704A JP 2005136704 A JP2005136704 A JP 2005136704A JP 4821957 B2 JP4821957 B2 JP 4821957B2
- Authority
- JP
- Japan
- Prior art keywords
- frequency
- electromagnetic wave
- treatment
- low
- mhz
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 83
- 229910001424 calcium ion Inorganic materials 0.000 claims description 83
- 230000000638 stimulation Effects 0.000 claims description 46
- 230000028023 exocytosis Effects 0.000 claims description 42
- 230000010355 oscillation Effects 0.000 claims description 42
- 208000002193 Pain Diseases 0.000 claims description 30
- 230000003834 intracellular effect Effects 0.000 claims description 30
- 230000001225 therapeutic effect Effects 0.000 claims description 25
- 230000036407 pain Effects 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 11
- 230000001360 synchronised effect Effects 0.000 claims description 11
- 210000004027 cell Anatomy 0.000 description 76
- 238000002474 experimental method Methods 0.000 description 45
- 230000000694 effects Effects 0.000 description 42
- 230000001965 increasing effect Effects 0.000 description 39
- 108010025020 Nerve Growth Factor Proteins 0.000 description 37
- 102000015336 Nerve Growth Factor Human genes 0.000 description 37
- 229940053128 nerve growth factor Drugs 0.000 description 37
- 230000000202 analgesic effect Effects 0.000 description 36
- 210000003141 lower extremity Anatomy 0.000 description 24
- 210000004498 neuroglial cell Anatomy 0.000 description 21
- 238000005259 measurement Methods 0.000 description 20
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 18
- 238000002653 magnetic therapy Methods 0.000 description 18
- 210000001130 astrocyte Anatomy 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 230000001976 improved effect Effects 0.000 description 16
- 239000011575 calcium Substances 0.000 description 14
- 230000008569 process Effects 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 101800005049 Beta-endorphin Proteins 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 9
- 230000009471 action Effects 0.000 description 9
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 9
- 230000008859 change Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 208000004454 Hyperalgesia Diseases 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 210000002569 neuron Anatomy 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 210000000170 cell membrane Anatomy 0.000 description 7
- 208000000094 Chronic Pain Diseases 0.000 description 6
- 208000035154 Hyperesthesia Diseases 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 230000036592 analgesia Effects 0.000 description 5
- 230000005684 electric field Effects 0.000 description 5
- 239000003623 enhancer Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 210000003497 sciatic nerve Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000004804 winding Methods 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- OZLGRUXZXMRXGP-UHFFFAOYSA-N Fluo-3 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(Cl)C(=O)C=C3OC3=CC(O)=C(Cl)C=C32)N(CC(O)=O)CC(O)=O)=C1 OZLGRUXZXMRXGP-UHFFFAOYSA-N 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000009610 hypersensitivity Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 239000012192 staining solution Substances 0.000 description 4
- 210000002504 synaptic vesicle Anatomy 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 206010065390 Inflammatory pain Diseases 0.000 description 3
- 208000005298 acute pain Diseases 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 230000000971 hippocampal effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 2
- 229960003132 halothane Drugs 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000036647 reaction Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 206010057040 Temperature intolerance Diseases 0.000 description 1
- APERIXFHHNDFQV-UHFFFAOYSA-N [2-[2-[2-[bis(carboxymethyl)amino]-5-methylphenoxy]ethoxy]-4-[3,6-bis(dimethylamino)xanthen-9-ylidene]cyclohexa-2,5-dien-1-ylidene]-bis(carboxymethyl)azanium;chloride Chemical compound [Cl-].C12=CC=C(N(C)C)C=C2OC2=CC(N(C)C)=CC=C2C1=C(C=1)C=CC(=[N+](CC(O)=O)CC(O)=O)C=1OCCOC1=CC(C)=CC=C1N(CC(O)=O)CC(O)=O APERIXFHHNDFQV-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000003674 cytoplasmic vesicle Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002518 glial effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000008543 heat sensitivity Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000005404 monopole Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 description 1
- 229950010357 tetrodotoxin Drugs 0.000 description 1
- CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
Images
Landscapes
- Magnetic Treatment Devices (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005136704A JP4821957B2 (ja) | 2005-05-09 | 2005-05-09 | 高周波治療器 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005136704A JP4821957B2 (ja) | 2005-05-09 | 2005-05-09 | 高周波治療器 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006311970A JP2006311970A (ja) | 2006-11-16 |
| JP2006311970A5 JP2006311970A5 (zh) | 2008-05-01 |
| JP4821957B2 true JP4821957B2 (ja) | 2011-11-24 |
Family
ID=37533716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005136704A Active JP4821957B2 (ja) | 2005-05-09 | 2005-05-09 | 高周波治療器 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4821957B2 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3885665A4 (en) * | 2019-10-31 | 2022-04-27 | Haier Shenzen Research and Development Co., Ltd | SCHUMANN WAVE GENERATOR AND WAVE MODULATION METHOD THEREOF, AS WELL AS AIR CONDITIONING |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103143118A (zh) * | 2013-03-28 | 2013-06-12 | 史德智 | 三椎治疗仪 |
| JP6612104B2 (ja) * | 2015-10-28 | 2019-11-27 | ピップ株式会社 | マイクロプレート |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH539438A (de) * | 1971-04-06 | 1973-07-31 | Kraus Werner | Elektrisches Gerät zur Förderung der Neubildung von Knochen- und Gewebesubstanz |
| US4813399A (en) * | 1986-07-18 | 1989-03-21 | Gordon Robert T | Process for the treatment of neurological or neuromuscular diseases and development |
| JP2002153268A (ja) * | 2000-09-05 | 2002-05-28 | Fuyuki Mitsuyama | 細胞機能亢進方法と細胞機能抑制方法とこれらに用いる薬剤および機械器具 |
| US7123010B2 (en) * | 2001-06-26 | 2006-10-17 | Siemens Aktiengesellschaft | Magnetic resonance apparatus and operation method for hyperthermic treatment |
-
2005
- 2005-05-09 JP JP2005136704A patent/JP4821957B2/ja active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3885665A4 (en) * | 2019-10-31 | 2022-04-27 | Haier Shenzen Research and Development Co., Ltd | SCHUMANN WAVE GENERATOR AND WAVE MODULATION METHOD THEREOF, AS WELL AS AIR CONDITIONING |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006311970A (ja) | 2006-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8951183B2 (en) | Neurotrophic factor production promoting device | |
| US5723001A (en) | Apparatus and method for therapeutically treating human body tissue with electromagnetic radiation | |
| US5106361A (en) | Method and apparatus for controlling the growth of non-osseous non-cartilaginous solid connective tissue | |
| US20060212077A1 (en) | Electromagnetic treatment apparatus for augmenting wound repair and method for using same | |
| US8343027B1 (en) | Methods and devices for providing electromagnetic treatment in the presence of a metal-containing implant | |
| RU2006129306A (ru) | Активация экспрессии гена белка, участвующего в остеогенезе (вмр), в костных клетках посредством электромагнитных сигналов | |
| US20100210893A1 (en) | Apparatus and method for electromagnetic treatment of plant, animal, and human tissue, organs, cells, and molecules | |
| US20130261374A1 (en) | Device and method for generating magnetic fields | |
| JP2009528073A (ja) | コイル一体型装置およびこれを使用する方法 | |
| JP2006519680A (ja) | 電磁治療器具および方法 | |
| JPS6141583B2 (zh) | ||
| EP2066393A1 (en) | Electromagnetic apparatus for respiratory disease and method for using same | |
| JPH0211170A (ja) | 磁場を印加して組織成長を制御する装置 | |
| JP2008538513A (ja) | 薬物、化学物質、及び局所薬の増強装置、並びにその使用方法 | |
| CN103764223A (zh) | 用于利用脉冲共振电磁波的治疗处理的设备 | |
| US20020052634A1 (en) | Method and system for modulation of oscillating signals to enhance biologic effects | |
| WO2007141874A1 (ja) | 疼痛治療器，高周波治療器 | |
| JP4821957B2 (ja) | 高周波治療器 | |
| RU2010137343A (ru) | Регуляция экспрессии фактора роста фибробластов-2 (fgf -2) в живых клетках с помощью применения специфических и избирательных электрических и электромагнитных полей | |
| CA1317639C (en) | Portable electro-therapy system | |
| JP2006311970A5 (zh) | ||
| RU2166970C1 (ru) | Способ воздействия на биологические объекты | |
| RU2221603C2 (ru) | Способ стимуляции репаративной регенерации костной ткани и устройство для его осуществления | |
| JPS6219183A (ja) | レ−ザ−光照射治療装置 | |
| RU2215561C1 (ru) | Способ воздействия на репаративную регенерацию костной ткани |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080314 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080314 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110308 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110427 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110726 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20110823 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110823 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110823 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4821957 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140916 Year of fee payment: 3 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |